It has been established that the expression of CD163 by NLC correlates with CLL proliferation in lymph nodes and the soluble counterpart of CD163 links with worst prognostic factors, such as TP53 mutations, complex karyotype. This evidence concerns the gene CD163 and B-cell chronic lymphocytic leukemia.